Listing 1 - 3 of 3 |
Sort by
|
Choose an application
"Since their discovery and subsequent development into laboratory tools, CRISPR Cas systems have revolutionized the science of gene editing and their possible applications continue to expand, from basic research to potentially groundbreaking medical and commercial uses. Led by a distinguished team of editors, CRISPR Biology and Applications explores the subject matter needed to delve into this fascinating area. This comprehensive text presents the diversity of CRISPR Cas systems, the underlying biology of these systems, and CRISPR based technologies and applications".
CRISPR (génétique). --- Génétique microbienne. --- Protéines de liaison à l'ARN. --- Microbial genetics. --- CRISPR-Cas Systems. --- Genetics, Microbial. --- RNA-Binding Proteins.
Choose an application
Dysregulation of Wnt signaling is known to be associated with various cancers. As such, identification of novel Wnt pathway targets in cancer and better characterization of already-known targets present exciting, emerging opportunities for cancer treatment. In this Special Issue, we feature papers which discuss the role of Wnt signaling and associated targets in cancer metabolism, tumor immune response, and tumor microenvironment. Papers discussing a range of Wnt-mediated cancers, including those of the colon, liver, pancreas, synovium, bladder, etc., are included.
Wnt signaling --- synovial sarcoma --- TNIK --- NCB-0846 --- MYC --- hepatitis B virus --- HBV --- cancer --- liver cancer --- β-catenin --- TCF/LEF --- pancreatic cancer --- pancreatic stellate cells --- CBP --- p300 --- pancreatitis --- fibrosis --- just-right signaling --- APC --- colorectal cancer --- RNA-binding proteins --- Musashi --- drug discovery --- Notch signaling --- cancer therapy --- fungi secondary metabolite derivative --- microenvironment --- Wnt --- AML --- drug target --- signaling --- colorectal --- porcupine --- R-spondin --- serrated --- immunotherapy --- wnt --- vitamin D --- colon cancer --- L1 --- Wnt target genes --- cell adhesion --- NF-κB --- invasion and metastasis --- cancer stem cells --- EMT --- Lgr5 --- Wnt/beta-catenin signaling --- angiogenesis --- anti-angiogenic therapy --- gastrointestinal cancers --- therapeutic targeting of Wnt signaling --- β-catenin paradox --- molecular targeting --- urothelial cancer --- immune checkpoint inhibitor --- immunotherapy resistance --- IBD --- colitis --- β-catenin mutations --- tumor metabolism --- tumor immunology --- molecular therapeutics --- precision medicine --- astrocytic brain tumors --- DKKs --- GSK3β
Choose an application
Dysregulation of Wnt signaling is known to be associated with various cancers. As such, identification of novel Wnt pathway targets in cancer and better characterization of already-known targets present exciting, emerging opportunities for cancer treatment. In this Special Issue, we feature papers which discuss the role of Wnt signaling and associated targets in cancer metabolism, tumor immune response, and tumor microenvironment. Papers discussing a range of Wnt-mediated cancers, including those of the colon, liver, pancreas, synovium, bladder, etc., are included.
Medicine --- Pharmacology --- Wnt signaling --- synovial sarcoma --- TNIK --- NCB-0846 --- MYC --- hepatitis B virus --- HBV --- cancer --- liver cancer --- β-catenin --- TCF/LEF --- pancreatic cancer --- pancreatic stellate cells --- CBP --- p300 --- pancreatitis --- fibrosis --- just-right signaling --- APC --- colorectal cancer --- RNA-binding proteins --- Musashi --- drug discovery --- Notch signaling --- cancer therapy --- fungi secondary metabolite derivative --- microenvironment --- Wnt --- AML --- drug target --- signaling --- colorectal --- porcupine --- R-spondin --- serrated --- immunotherapy --- wnt --- vitamin D --- colon cancer --- L1 --- Wnt target genes --- cell adhesion --- NF-κB --- invasion and metastasis --- cancer stem cells --- EMT --- Lgr5 --- Wnt/beta-catenin signaling --- angiogenesis --- anti-angiogenic therapy --- gastrointestinal cancers --- therapeutic targeting of Wnt signaling --- β-catenin paradox --- molecular targeting --- urothelial cancer --- immune checkpoint inhibitor --- immunotherapy resistance --- IBD --- colitis --- β-catenin mutations --- tumor metabolism --- tumor immunology --- molecular therapeutics --- precision medicine --- astrocytic brain tumors --- DKKs --- GSK3β
Listing 1 - 3 of 3 |
Sort by
|